Urology Cancer Specialist Dr. Jeffrey Holzbeierlein

Jeffrey Holzbeierlein, MD, FACS | KU UrologyПодробнее

Jeffrey M. Holzbeierlein, MD, highlights the most promising data coming out of ASCO GU 2017Подробнее

Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder CancerПодробнее

Dr. Holzbeierlein on the Management of Bladder Cancer GuidelinesПодробнее

Jeffrey M. Holzbeierlein, MD, offers his opinion on interesting presentations from ASCO GU 2017Подробнее

Jeffrey M. Holzbeierlein, MD, gives his perspective on treatment trends in urology for 2017Подробнее

Jeffrey M. Holzbeierlein, MD, on the impact of his data presented at ASCO GU 2017Подробнее